IKT Inhibikase Therapeutics Inc Com

  0%
Previous Close
Open
52 Week Low
52 Week High
Market Cap $0
Shares 9,605,251
Float 4,303,550
Enterprise Value $0
Volume 0
Av. Daily Volume 0
Stock charts supplied by TradingView

Drug Pipeline

Drug Stage Notes
IkT-148009
Parkinson’s disease
Phase 1b
Phase 1b
Phase 1b trial to be initiated in 2021.